TY  - GEN
AU  - Campbell,H E
AU  - Epstein,D
AU  - Bloomfield,D
AU  - Griffin,S
AU  - Manca,A
AU  - Yarnold,J
AU  - Bliss,J
AU  - Johnson,L
AU  - Earl,H
AU  - Poole,C
AU  - Hiller,L
AU  - Dunn,J
AU  - Hopwood,P
AU  - Barrett-Lee,P
AU  - Ellis,P
AU  - Cameron,D
AU  - Harris,A L
AU  - Gray,A M
AU  - Sculpher,M J
TI  - The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses
SN  - 1879-0852
PY  - 2012///0103
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - economics
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Chemotherapy, Adjuvant
KW  - Cost-Benefit Analysis
KW  - Cyclophosphamide
KW  - Docetaxel
KW  - Epirubicin
KW  - Female
KW  - Fluorouracil
KW  - Health Care Costs
KW  - Humans
KW  - Methotrexate
KW  - Middle Aged
KW  - Prognosis
KW  - Quality-Adjusted Life Years
KW  - Taxoids
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1016/j.ejca.2011.06.019
ER  -